1. From the Department of Molecular Medicine, A.I. Virtanen Institute, University of Kuopio, Finland (P.L., S.K., I.K., J.K., S.Y.-H.); the Departments of Medicine (S.Y.-H.) and the Gene Therapy Unit (S.Y.-H.), Kuopio University Hospital, Kuopio, Finland; the Ludwig Institute for Cancer Research (C.F., U.E.), Stockholm, Sweden; and the Cancer Biology Laboratory (K.A.), Biomedicum, University of Helsinki, Helsinki, Finland.